Welcome to our dedicated page for Axcelis Tech Ord news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Tech Ord stock.
Axcelis Technologies reports developments tied to its role as a supplier of ion implantation systems and process applications for semiconductor manufacturing. Company updates commonly cover quarterly results, demand trends across memory, power, compound semiconductor and mature-node markets, and the performance of its customer support and installed-base services business.
News also includes technical participation at semiconductor industry conferences, lifecycle support for Purion-based implant platforms, sustainability targets for greenhouse gas emissions, investor-conference activity and governance changes such as finance leadership transitions. The recurring business context centers on equipment used in integrated-circuit fabrication and aftermarket services including spare parts, upgrades, maintenance and training.
Axcelis Technologies (NASDAQ: ACLS) will participate in the 13th Annual Virtual CEO Summit on June 15, 2021. The event will feature small group meetings with management teams from various companies, offering investors and analysts an opportunity to engage directly. Axcelis will provide presentation materials on their investor page, accessible via www.axcelis.com. Attendance is by invitation only, requiring advance registration before June 10, 2021.
Axcelis Technologies, Inc. (NASDAQ: ACLS) announced participation in upcoming virtual investor conferences. Key events include the 18th Annual Craig-Hallum Institutional Investor Conference on June 2, the 49th Annual Cowen 2021 Technology, Media & Telecom Conference on June 3, and the Stifel 2021 Virtual Cross Sector Insight Conference on June 9. Management will conduct virtual one-on-ones and small group meetings, with a fireside chat scheduled for June 9 at 10:40 a.m. ET. A live webcast will be available via Axcelis' website.
Axcelis Technologies reported first quarter 2021 revenue of $132.8 million, an increase from $122.2 million in Q4 2020. The operating profit rose to $20.3 million from $14.1 million, with net income at $16.5 million ($0.48/share), up from $14.7 million ($0.43/share). The gross margin declined slightly to 42.5% from 43.4%. The company shipped its first Purion H200™ SiC tool and anticipates 2021 revenue to exceed $550 million. For Q2 2021, revenue is expected between $135 million and $140 million.
Axcelis Technologies, Inc. (Nasdaq: ACLS) will release its first quarter 2021 financial results on May 4, 2021, at 4:00 p.m. ET. The company will hold a conference call to discuss the results the following day, May 5, 2021, at 8:30 a.m. ET. Interested listeners can access the call via the company's Investor page. Founded over 40 years ago, Axcelis is known for providing high-productivity solutions for the semiconductor industry, focusing on ion implantation systems.
Axcelis Technologies, Inc. (Nasdaq: ACLS) announced multiple follow-on shipments of its Purion M™ SiC medium current implanter to leading power device manufacturers in Europe. This first-quarter shipment supports the growing demand for silicon carbide (SiC) power devices, particularly in the automotive, mobile, and IoT sectors. Executive Vice President Bill Bintz highlighted the importance of enhancing manufacturing capabilities to meet supply challenges driven by increasing electrification in the automotive industry.
Axcelis Technologies (Nasdaq: ACLS) announced multiple shipments of its Purion VXE™ high energy systems to leading manufacturers of CMOS image sensors. These systems are designed to meet the demands of increased productivity in the semiconductor industry. Axcelis emphasizes its leadership in high-energy implant technology, which is critical for the image sensor market, projected to maintain strong growth driven by the IoT, mobile, and automotive sectors. The Purion product family offers various options for customized energy levels.
On March 8, 2021, Axcelis Technologies (Nasdaq: ACLS) announced the shipment of its first Purion H200 SiC Power Series™ implanter. This advanced equipment, designed for silicon carbide applications, was sent to a key power device manufacturer to support production ramp-up. The Purion H200 is the only single wafer high current implanter tailored for high dose implant applications. CEO Mary Puma highlighted the growing market for power devices, which represented over 17% of 2020 system sales, signaling significant revenue potential for Axcelis.
Axcelis Technologies (Nasdaq: ACLS) has announced its participation in two upcoming virtual investor conferences. The first is the Susquehanna Financial Group Tenth Annual Technology Conference on March 9, 2021, where management will engage in virtual one-on-ones and small group meetings. The second is the B. Riley Inaugural Clean Tech and Sustainability Virtual Investor Conference on March 10, 2021, featuring a fireside chat at 10:30 am EST with subsequent one-on-one meetings. A replay of the latter event will be available afterward.
Axcelis Technologies (Nasdaq: ACLS) announced the shipment of its second Purion XEmax high energy evaluation system to a leading foundry in the Asia Pacific region, aimed at CMOS image sensor manufacturing. This shipment, part of the first quarter, aligns with Axcelis' goal of reaching a $650M target business model amid increasing demand for high energy implants in the image sensor market. The Purion XEmax features enhanced capabilities, including patented Boost Technology™ for precise control, and builds on the established Purion XE platform for improved photodiode performance.
Axcelis Technologies (ACLS) reported strong financial results for Q4 and full year 2020. Q4 revenue reached $122.2 million, up from $110.4 million in Q3. Net income rose to $14.7 million or $0.43 per diluted share, benefiting from a $0.11 tax benefit. For the year, revenue surged to $474.6 million, a 38% increase from 2019, with net income of $50.0 million and diluted EPS of $1.46. Looking ahead, Q1 2021 revenue is expected between $118 million and $138 million.